Intellectual Property India Publishes Patent Application for 'Heterocyclic Derivatives As Janus Kinase Inhibitors' Filed by Chiesi Farmaceutici S. P. A.

MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202517032593 A) filed by Chiesi Farmaceutici S. P. A., Parma, Italy, on April 2, for 'heterocyclic derivatives as janus kinase inhibitors.'

Inventor(s) include Accetta, Alessandro; Cuzzolin, Alberto; Rancati, Fabio; Rizzi, Andrea; Elenkov, Ivaylo Jivkov; Mesic, Milan; and Radosevic, Ela.

The application for the patent was published on April 25, under issue no. 17/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to a compounds of general formula (I) inhibiting the JAK family of non-receptor tyrosine protein kinases (JAK1, JAK2, JAK3, and TYK2); methods of preparing such compounds, pharmaceut...